IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,980,509 | -35.4% | 655,057 | 0.0% | 0.33% | +2.8% |
| Q2 2023 | $4,611,601 | +15.2% | 655,057 | 0.0% | 0.32% | +14.4% |
| Q1 2023 | $4,002,398 | +95513.9% | 655,057 | 0.0% | 0.28% | -42.3% |
| Q4 2022 | $4,186 | -99.9% | 655,057 | 0.0% | 0.48% | -30.4% |
| Q3 2022 | $6,275,000 | -13.2% | 655,057 | 0.0% | 0.69% | -4.5% |
| Q2 2022 | $7,232,000 | -33.7% | 655,057 | 0.0% | 0.73% | -3.3% |
| Q1 2022 | $10,907,000 | +89.8% | 655,057 | +117.6% | 0.75% | +117.1% |
| Q4 2021 | $5,746,000 | -85.4% | 301,000 | -81.2% | 0.35% | -90.6% |
| Q2 2019 | $39,232,000 | +157.8% | 1,600,000 | 0.0% | 3.68% | +142.3% |
| Q1 2019 | $15,216,000 | +7.5% | 1,600,000 | 0.0% | 1.52% | -16.1% |
| Q4 2018 | $14,160,000 | – | 1,600,000 | – | 1.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |